Composition: Clindamycin Phosphate 100 mg + Clotrimazole 100 mg + Tinidazole 100 mg with Applicator (vaginal capsules). The rationale for the combination is complementary action: Clindamycin (lincosamide antibiotic), Clotrimazole (azole antifungal) and Tinidazole (nitroimidazole antimicrobial).
Clindamycin is a lincosamide antibiotic active against Gram-positive and anaerobic bacteria. Clotrimazole is an azole antifungal that inhibits ergosterol synthesis in the fungal cell membrane. Tinidazole is a nitroimidazole active against anaerobic bacteria and protozoa such as Trichomonas vaginalis.
CLOTREE-7 is a prescription medicine from Aerochem Neutron's gynaecology range, for use on the prescription of a registered medical practitioner.
· Contains Clindamycin Phosphate 100 mg + Clotrimazole 100 mg + Tinidazole 100 mg with Applicator
· Clindamycin — lincosamide antibiotic active against Gram-positive and anaerobic bacteria
· Clotrimazole — azole antifungal that inhibits ergosterol synthesis in the fungal cell membrane
· Tinidazole — nitroimidazole active against anaerobic bacteria and protozoa such as Trichomonas vaginalis
· Presented as vaginal capsules
· Bacterial vaginosis
· Vaginal candidiasis
· Trichomonal vaginitis
· Mixed vaginal infections
· Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination
Safety
· Contraindicated in patients with known hypersensitivity to any component.
· Clindamycin carries a significant risk of C. difficile-associated diarrhoea and colitis.
· Local irritation may occur; vaginal products can damage latex condoms.
· Nitroimidazoles may cause metallic taste, gastrointestinal upset and, rarely, peripheral neuropathy or seizures; avoid alcohol during and shortly after therapy and use caution in the first trimester of pregnancy.
· Refer to the full prescribing information for all contraindications and interactions.
Clinical Rationale: The mechanisms and labelled uses of clindamycin, clotrimazole, tinidazole described here follow the US prescribing information (DailyMed). Use of the combination should follow the CDSCO-approved label for this fixed-dose combination.
References
· DailyMed (US NLM) prescribing information – clindamycin: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=CLINDAMYCIN
· DailyMed (US NLM) prescribing information – clotrimazole: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=CLOTRIMAZOLE
DailyMed (US NLM) prescribing information – tinidazole: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TINIDAZOLE
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about Clotree 7 Softgel for professional use.